19 /100
LOW RISK
Score updated Jul 13, 2026

CGEN — Compugen Ltd. Dilution Risk Tracker

Track CGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CGEN — Get alerts when the score changes →

As of July 13, 2026, Compugen Ltd. (CGEN) has a DilutionWatch DilutionScore of 19/100, rated LOW dilution risk. Compugen Ltd. has a market capitalization of $248.76M, 94.55M shares outstanding, 79 institutional holders tracked. Key dilution vectors include 89.6K outstanding warrants, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CGEN.
🔔 Track CGEN — Get forecast alerts →

💹 Market Data

Market Cap$248.76M
Shares Outstanding94.55M
Float92.42M
Cash$99.88M
Debt$2.93M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 30.2% shares (2026Q1 vs prior)
79 institutional holders · 16.47M shares
#1 SILVERARC CAPITAL MANAGEMENT, LLC 3.32M shares
#2 MORGAN STANLEY 3.12M shares
#3 RENAISSANCE TECHNOLOGIES LLC 1.63M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.80M
Days to Cover10.0
% of Float3.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CGEN Shareholders

Compugen Ltd. (CGEN) has a DilutionScore of 19/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CGEN shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CGEN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CGEN alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CGEN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CGEN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CGEN
📊 CGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CGEN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.